Protection of the spinal cord from ischemia: Comparative effects of levosimendan and iloprost

European Surgical Research

Volumn 41, Issue 1, 2008, Pages 1-7

  Lafci, B ^a,c   Yasa, H ^a   Ilhan, G ^a   Ortac, R ^b   Yilik, L ^a   Kestelli, M ^a   Goktogan, T ^a   Gurbuz, A ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Dr Behcet Uz Childrens Public Hospital   (Turkey)

^c NONE   (Turkey)

Author keywords

Iloprost; Ischemia reperfusion injury; Levosimendan

Indexed keywords

ILOPROST; LEVOSIMENDAN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA BIFURCATION; AORTA CLAMPING; ARTERY CLAMP; ARTICLE; BLOOD FLOW; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; LOADING DRUG DOSE; MALE; MONOTHERAPY; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RABBIT; RANDOMIZATION; RENAL ARTERY; REPERFUSION INJURY; SPINAL CORD ISCHEMIA; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TREATMENT OUTCOME;

ANIMALS; HYDRAZONES; ILOPROST; PYRIDAZINES; RABBITS; SPINAL CORD ISCHEMIA; TIME FACTORS; VASODILATOR AGENTS;

EID: 46749126210     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000121394     Document Type: Article

References (37)

1. Mauney MC, Blackburne LH, Langenburg SE, Buchanan SA, Kron IL, Tribble CG: Prevention of spinal cord injury after repair of the thoracic or thoracoabdominal aorta. Ann Thorac Surg 1995;59:245-252.
2. Silistreli E, Kabakci B, Yilmaz E, Sonmez A, Erdal C, Karabay O, Catalyurek H, Canda S, Acikel U: Early protective effects of iloprost, a stable prostacyclin analog, during spinal cord ischemia in a rabbit model. Heart Vessels 2005;20:66-71.
3. Herold JA, Kron IL, Langenburg SE, Blackburne LH, Tribble CG: Complete prevention of postischemic spinal cord injury by means of regional infusion with hypothermic saline and adenosine. J Thorac Cardiovasc Surg 1994;107:536-542.
4. Marini CP, Levison J, Caliendo F, Nathan IM, Cohen JR: Control of proximal hypertension during aortic cross-clamping: its effect on cerebrospinal fluid dynamics and spinal cord perfusion pressure. Semin Thorac Cardiovasc Surg 1998;10:51-56.
5. Verdant A, Page A, Cossette R, Dontigny L, Page P, Baillot R: Surgery of the descending thoracic aorta: spinal cord protection with the Gott shunt. Ann Thorac Surg 1988;46:147-154.
6. Drenger B, Parker SD, McPherson RW, North RB, Williams GM, Reitz BA, Beattie C: Spinal cord stimulation evoked potentials during thoracoabdominal aortic aneurysm surgery. Anesthesiology 1992;76:689-695.
7. Tator CH: Biology of neurological recovery and functional restoration after spinal cord injury. Neurosurgery 1998;42:696-708.
8. Young W: The role of calcium in spinal cord injury. Cent Nerv Syst Trauma 1985;2:109-114.
9. Cakir O, Erdem K, Oruc A, Kilinc N, Eren N: Neuroprotective effect of N-acetylcysteine and hypothermia on the spinal cord ischemia-reperfusion injury. Cardiovasc Surg 2003;11:375-379.
10. Lang-Lazdunski L, Heurteaux C, Dupont H, Widmann C, Lazdunski M: Prevention of ischemic spinal cord injury: comparative effects of magnesium sulfate and riluzole. J Vasc Surg 2000;32:179-189.
11. Tetik O, Islamoǧlu F, Yagdi T, Atay Y, Çalkavur T, Özbek C, Canpolat L, Buket S, Yuksel M: An intraaortic solution trial to prevent spinal cord injury a rabbit model. Eur J Vasc Endovasc Surg 2001;22:175-179.
12. Ng TM: Levosimendan, a new calcium-sensitizing inotrope for heart failure. Pharmacotherapy 2004;24:1366-1384.
13. Bowman P, Haikala H, Paul RJ: Levosimendan, a calcium sensitizer in cardiac muscle, induces relaxation in coronary smooth muscle through calcium desensitization. J Pharmacol Exp Ther 1999;288:316-325.
14. Kertsen JR, Montgomery MW, Pagel PS, Warltier DC: Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels. Anesth Analg 2000:90:5-11.
15. Johnson SH, Kraimer JM, Graeber GM: Effects of flunarizine on neurological recovery and spinal cord blood flow in experimental spinal cord ischemia in 20 rabbits. Stroke 1993;24:1547-1553.
16. Coşkun K, Attar A, Tuna H, Sargon MF, Yüceer N, Türker NK, Egemen N: Early protective effect of iloprost after experimental spinal cord ischemia in rabbits. Acta Neurochir 2000;142:1143-1150.
17. Reyes E, Sosa I, Kuffler DP: Neuroprotection of spinal neurons against blunt trauma and ischemia. P R Health Sci J 2003;22:277-286.
18. Crawford ES, Rubia PA: Reappraisal of adjuncts to avoid ischemia in the treatment of aneurysms of descending thoracic aorta. J Thorac Cardiovasc Surg 1973;66:693-704.
19. Egemen N, Birler K, Avman N, Türker RK: Experimental cerebral vasospasm: resolution by iloprost. Acta Neurochir 1988;95:131-135.
20. Ferrari R, Cargnoni A, Ceconi C, Curella S, Belloli S, Albertini A, Visioli O: Protective effect of a prostacyclin-mimic on the ischaemic-reperfused rabbit myocardium. J Mol Cell Cardiol 1988;20:1095-1106.
21. Türker RK, Egemen N, Deda H: Cerebral vasospasm: resolution by iloprost, nocloprost and UK 38485. Prog Clin Biol Res 1989;301:205-209.
22. Witt W, Muller B: Antithrombotic profile of iloprost in experimental models of in vivo platelet aggregation and thrombosis. Adv Prostaglandin Thrombaxane Leukot Res 1987;17:607-616.
23. Katircioglu SF, Ulus AT, Gokce P, Surucu S: Iloprost protects the spinal cord during aortic cross-clamping in a canine model. J Cardiovasc Surg 200;41:89-93.
24. Taoka Y, Okajima K, Uchiba M, Murakami K, Harada N, Johno M, Naruo M: Reduction of spinal cord injury by administration of iloprost, a stable prostacyclin analog. J Neurosurg 1997;86:1007-1011.
25. Follath F, Cleland JG, Just H, Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study: Efficacy and safety of intravenous levosimendan compared with dopamine in severe low-output heart failure (the LIDO study): a randomized double-blind trial. Lancet 2002;360:196-202.
26. Parissis J, Adamopoulos S, Antoniades C, Kostakis G, Rigas A, Kyrzopoulos S, Iliodronitis E, Kremastinos D: Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure. Am J Cardiol 2004;93:1309-1312.
27. Haikala H, Kaivola J, Nissinen E, Wall P, Levijoki J, Linden I-B: Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan. J Mol Cell Cardiol 1995;27:1859-1866.
28. + channel in rat myocytes. Eur J Pharmacol 1996;333:240-259.
29. Zivin JA, DeGirolami U: Spinal cord infarction: a highly reproducible stroke model. Stroke 1980;11:200-202.
30. Sirin BH, Yilik L, Ortaç R, Coşkun E, Şirin H, Çelebisoy N: Aprotinin reduces injury of the spinal cord in transient ischemia. Eur J Cardiothorac Surg 1997;12:913-918.
31. Barone B, Pavoun C, Blin PC, Cuq P: Nervous System, Atlas of Rabbit Anatomy. Paris, Masson & Cie, 1973, pp 147-174.
32. Barone B, Pavoun C, Blin PC, Cuq P: Nervous System, Atlas of Rabbit Anatomy. Paris, Masson & Cie, 1973, pp 115-128.
33. Zivin JA, Waud DR: A precise and sensitive method for measurement of spinal cord blood flow. Brain Res 1983;258:197-200.
34. Boga M, Discigil B, Ozkisacik EA, Gurcun U, Badak MI, Dikicioglu E, Yenisey C, Meteoglu I: The combined effect of iloprost and N-acetylcysteine in preventing spinal cord ischemia in rabbits. Eur J Vasc Endovasc Surg 2006;31:366-376.
35. Chen S, Xiong L, Wang Q, Sang H, Zhu Z, Dong H, Lu Z: Tetramethylpyrazine attenuates spinal cord ischemic injury due to aortic cross-clamping in rabbits. BMC Neurol 2002;2:1-6.
36. Carbajal D, Arruzazabala ML, Noa M, Molina V, Más R, Arango E, Valdés S, Gonzalez JE: Protective effect of D-003 on experimental spinal cord ischemia in rabbits. Prostaglandins Leukot Essent Fatty Acids 2004;70:1-6.
37. Lee CJ, Kim KW, Lee HM, Nahm FS, Lim YJ, Park JH, Kim CS: The effect of thalidomide on spinal cord ischemia/reperfusion injury in a rabbit model. Spinal Cord 2007;45:149-157.